The present findings showed low incidence of BRAF V600E mutation in the studied lung cancer population, and that the newly established RT-qPCR method and BRAF V600E-specific antibody have high concordance in BRAF V600E detection. This evidence concerns the gene BRAF and lung carcinoma.